Safety and Traceability in the Wake of GE Healthcare's FBS Recall- An interview with Rosemary Versteegen

Hosted By: Gerald Clarke
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

When GE Healthcare recently withdrew their Fetal Bovine Serum (FBS) products due to non-conformancies, it highlighted the real need for product safety and traceability practices in the field. Pharma IQ spoke to Rosemary Versteegen, CEO of the International Serum Industry Association about this case and what the industry can learn from it.


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018